1,4-Dioxane → HCID 22053589, compound
Reaction equation
C(O[C:6]([N:8]1[CH2:14][CH2:13][CH2:12][NH:11][CH2:10][CH2:9]1)=[O:7])(C)(C)C.[CH:15](N(C(C)C)CC)(C)C.O1CCOCC1.[F:30][C:31]([F:68])([F:67])[C:32]1[CH:33]=[C:34]([CH:60]=[C:61]([C:63]([F:66])([F:65])[F:64])[CH:62]=1)[CH2:35][N:36]1[CH2:43][CH2:42][CH2:41][NH:40][C:39]2[N:44]=[C:45](S(C)(=O)=O)[N:46]=[C:47]([C:48]3[CH:53]=[CH:52][CH:51]=[CH:50][C:49]=3[CH3:54])[C:38]=2[C:37]1=[O:59]>C(OCC)(=O)C>[C:6]([N:8]1[CH2:14][CH2:13][CH2:12][N:11]([C:45]2[N:46]=[C:47]([C:48]3[CH:53]=[CH:52][CH:51]=[CH:50][C:49]=3[CH3:54])[C:38]3[C:37](=[O:59])[N:36]([CH2:35][C:34]4[CH:60]=[C:61]([C:63]([F:66])([F:65])[F:64])[CH:62]=[C:32]([C:31]([F:30])([F:68])[F:67])[CH:33]=4)[CH2:43][CH2:42][CH2:41][NH:40][C:39]=3[N:44]=2)[CH2:10][CH2:9]1)(=[O:7])[CH3:15]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
1-(t-butoxycarbonyl)homopiperazine (36.1 mg), diisopropylethylamine (0.1 mL) and 1,4-dioxane (1 mL) were added to 6-[3,5-bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-2-(methylsulfonyl)-5-oxopyrimido[4,5-b][1,5]diazocine (Compound of Reference Example 19; 85.9 mg). While heated, the mixture was refluxed for 5 hours. The reaction mixture was then diluted with ethyl acetate, was washed with water, and was then dried over anhydrous sodium sulfate. The solvent was removed and 3 mol/L hydrogen chloride/ethyl acetate (1 mL) was added while the residue was chilled on an ice bath. The mixture was stirred for 30 min and then additional 1 hour at room temperature. Following removal of the solvent, the residue was dissolved in tetrahydrofuran (1 mL). While the residue was chilled on an ice bath, triethylamine (0.1 mL) and anhydrous acetic acid (0.05 mL) were added and the mixture was stirred at room temperature for 30 min. Subsequently, the reaction mixture was diluted with ethyl acetate, was washed with water, and was then dried over anhydrous sodium sulfate. Following removal of the solvent, the residue was purified on a silica gel column chromatography (ethyl acetate:methanol=10:1) to obtain 2-(4-acetylhomopiperazine-1-yl)-6-[3,5-bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-5-oxopyrimido[4,5-b][1,5]diazocine (70.7 mg, 74%).
Workup
- temperatureWhile heated
- temperaturethe mixture was refluxed for 5 hours
- washwas washed with water
- dry with materialwas then dried over anhydrous sodium sulfate
- customThe solvent was removed
- addition3 mol/L hydrogen chloride/ethyl acetate (1 mL) was added while the residue
- temperaturewas chilled on an ice bath
- customadditional 1 hour
- customat room temperature
- customremoval of the solvent
- dissolutionthe residue was dissolved in tetrahydrofuran (1 mL)
- temperatureWhile the residue was chilled on an ice bath
- additiontriethylamine (0.1 mL) and anhydrous acetic acid (0.05 mL) were added
- stirringthe mixture was stirred at room temperature for 30 min
- additionSubsequently, the reaction mixture was diluted with ethyl acetate
- washwas washed with water
- dry with materialwas then dried over anhydrous sodium sulfate
- customremoval of the solvent
- customthe residue was purified on a silica gel column chromatography (ethyl acetate:methanol=10:1)
Sources & evidence
- ORD record
- ord-a0f77c24a89d4246b819ba2e7efdebd5
- Source dataset
- uspto-grants-2006_06
- Patent number
- US07064119B2
Reaction notes
Loading…